Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Shelley Wood

April 25, 2023

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Todd Neale

August 19, 2022

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

Advertisement

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Women Stand to Gain the Most From Standardized STEMI Protocols

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content